Abstract:H epatoblastoma (HB) is a common pediatric liver cancer that could originate from embryonal and fetal liver cells. The etiology of HB is mostly unclear; however, it is well known that certain inherited conditions including familial adenomatous polyposis (FAP) and Beckwith-Wiedemann Syndrome, as well as congenital anomalies and low birth weight, may dramatically raise the risk of HB. The unique clinical features of HB suggest that developmental factors as well as the interactions between genetic and environmental elements may affect the self-renewal and differentiation of hepatic stem/progenitor cells, and lead to the malignant transformation during embryogenesis. However, the exact mechanism by which normal hepatic development is malignantly transformed to HB remains obscure. Previous investigations have uncovered a number of genetic aberrations in HB. FAP cases with HB are caused by heritable germline mutation of tumor suppressor gene adenomatous polyposis coli (APC). However, the unique germline APC mutations are rare in sporadic HB cases. In sporadic HB cases, the most prevalent somatic mutations involve the genes encoding components of the Wnt-b-catenin pathway which play a critical role in embryonic and fetal liver development. In addition to the low APC mutations found in HB cases, the most common recurrent mutations occur in CTNNB1, which encodes b-catenin, a key component of the Wnt-b-catenin pathway. The occurrence of genetic aberrations, including point mutations and in-frame deletion of the third exon in CTNNB1, has been reported as to be high as 75% of HB tumors. Moreover, the loss-of-function somatic mutations of tumor suppressor genes AXIN1 and AXIN2 whose products affect the b-catenin degradation have also been reported in some HB (Fig. 1). In normal cells, the Nterminal serine and threonine residues of b-catenin encoded by exon 3 of CTNNB1 are phosphorylated by the APC/AXIN/GSK3b complex, and result in bcatenin ubiquitination and subsequent degradation. The constitutive activity of Wnt-b-catenin pathway, which is caused by the gain-of-function mutations of CTNNB1 or loss-of-function mutations of APC and AXIN1/2, leads to the cytoplasmic and nuclear accumulation of bcatenin, and then activates the expression of many target genes, including cyclin D1 for cell proliferation, by the binding of b-catenin to the transcription factors TCF/ LEF. In addition to the Wnt-b-catenin pathway, based on the conventional Sanger sequencing of selected genes, the acquired somatic mutations of the components in other signaling pathways are infrequently found in sporadic HB cases. Whole genome and exome sequencing have been successfully applied in uncovering the somatic mutations in malignancies, including hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Significantly, in this issue of HEPATOLOGY, Jia et al. performed exome sequencing on six sporadic HB cases, and exhibited the first mutational landscape of pediatric liver cancer. They found 144 somatic mutations, including 28 nonsynonymous mutations, with an average of 4.67 nonsilenced mutations per case. The numbers of somatic mutations in the pediatric HB are far less than those in adult HCC and ICC, implying that a few driver mutations may initiate the malignant transformation of HB in embryonal and fetal livers. In this study, they confirmed 24 nonsynonymous mutations within 21 genes by Sanger sequencing. As expected, the point mutations of CTNNB1 exist in two of the six HB tumors. These point mutations include a previous uncharacterized mutation (G512V), located near the armadillo repeat domain of b-catenin. The domain of b-catenin can interact with many binding partners that affect its stability and localization. Like other known CTNNB1 mutations, the G512V is documented as a gain-of-function mutation that significantly Abbreviations: APC, adenomatous polyposis coli; CUL3, cullin 3FAP, familial adenomatous polyposis; HB, hepatoblastoma; HCC, hepatocellular carcinoma; ICC, intrahepatic cholangiocarcinoma. Received June 26, 2014; accepted July 26, 2014. Address reprint requests to: Ze-Guang Han, M.D., Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, 800 Dong Chuan Road, Shanghai 200240, China. E-mail: hanzg@sjtu.edu.cn; fax: 186-2134206059. Copyright VC 2014 by the American Association for the Study of Liver Diseases. View this article online at wileyonlinelibrary.com. DOI 10.1002/hep.27347 Potential conflict of interest: Nothing to report.

Whole-genome sequencing and RNA sequencing analysis reveals novel risk genes and differential expression patterns in hepatoblastoma

Exome Sequencing of Hepatoblastoma Reveals Novel Mutations and Cancer Genes in the Wnt Pathway and Ubiquitin Ligase Complex

Trans-Ancestry Mutation Landscape of Hepatoblastoma Genomes in Children

LIN28B Gene Polymorphisms Modify Hepatoblastoma Susceptibility in Chinese Children

Single-cell transcriptomics uncovers cellular architecture and developmental trajectories in hepatoblastoma

Molecular Mechanisms of Hepatoblastoma

Whole exome sequencing identified genetic variations in Chinese hemangioblastoma patients

Whole-Genome Sequencing Identifies a Novel Variation of WAS Gene Coordinating With Heterozygous Germline Mutation of APC to Enhance Hepatoblastoma Oncogenesis.

Whole Genome Sequencing of Matched Tumor, Adjacent Non-Tumor Tissues and Corresponding Normal Blood Samples of Hepatocellular Carcinoma Patients Revealed Dynamic Changes of the Mutations Profiles During Hepatocarcinogenesis.

Mutational Landscape of Hepatoblastoma Goes Beyond the Wnt-β-catenin Pathway.

Whole-genome Sequencing Identifies Recurrent Mutations in Hepatocellular Carcinoma.

Asynchronous Transitions from Hepatoblastoma to Carcinoma in High-Risk Pediatric Tumors

Abstract LB-229: Whole genome sequencing reveals genetic landscape of hepatocellular carcinoma.

Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis.

Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma

Intratumoral CXCR4hi neutrophils display ferroptotic and immunosuppressive signatures in hepatoblastoma

Global Profiling of O-GlcNAcylated And/or Phosphorylated Proteins in Hepatoblastoma

Prognostic Value of a Novel Multi-mRNA Signature for Predicting Disease Progression of Hepatoblastoma

Alternative Splicing of lncRNAs From SNHG Family Alters snoRNA Expression and Induces Chemoresistance in Hepatoblastoma.

From Diagnosis to Therapy: The Critical Role of lncRNAs in Hepatoblastoma

A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation—a 14-year retrospective study from a single center